MiR-185-5p Protects Against Angiogenesis in Polycystic Ovary Syndrome by Targeting VEGFA
Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine disease with high incidences in women of reproductive age. Although miR-185-5p (miR-185) was decreased in PCOS patients, the exact function of miR-185 on PCOS development still requires further investigation. In this study, rat injected w...
Saved in:
Main Authors: | Jingzan Wei (Author), Yanyan Zhao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer
by: Jing Tian, et al.
Published: (2022) -
ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis
by: Xuan Li, et al.
Published: (2020) -
VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy
by: Sidsel Alsing, et al.
Published: (2022) -
Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
by: Xiaoyuan Xu, et al.
Published: (2023) -
miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
by: Li Zhou, et al.
Published: (2018)